The French Competition Authority adopts an innovative merger decision in the healthcare institution sector assessing not only the effects on medical services but also non-medical ancillary services (Médipôle-Partenaires / Elsan)

de Saint-Bon (d'Harcourt) , Maëlle

Previous article The French Competition Authority dismisses a complaint accusing the incumbent railway company of abuse of dominance (Transdev) Next article The EU Commission clears a merger subject to remedies in the chemicals market (Huber Silica / Evonik)

23 Jun 2017

The French Competition Authority adopts an innovative merger decision in the healthcare institution sector assessing not only the effects on medical services but also non-medical ancillary services (Médipôle-Partenaires / Elsan)

KEYWORDS

Reference

French Competition Authority, Médipôle-Partenaires / Elsan, Press release, 23 June 2017

The French Competition Authority (FCA) has adopted an innovative merger decision in the health care institution sector, assessing not only the effects of the operation on medical services (diagnostic and treatments), but also the effects on non-medical ancillary services. An innovative merge clearance decision in the healthcare institutions’ sector The decision has not been published yet (press release of 23 July 2017). The operation

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Maëlle de Saint-Bon (d’Harcourt)
TotalEnergies (Paris)

France 5 contributions 3355 visits

Quotation

Maëlle de Saint-Bon (d'Harcourt), The French Competition Authority adopts an innovative merger decision in the healthcare institution sector assessing not only the effects on medical services but also non-medical ancillary services (Médipôle-Partenaires / Elsan), 23 June 2017, e-Competitions June 2017, Art. N° 84759

Visites 304